CCC
TWST icon

Chesapeake Capital Corp’s Twist Bioscience TWST Stock Holding History

Chesapeake Capital Corp’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$286K Sell
6,148
-28
-0.5% -$1.26K 0.29% 141
2024
Q3 		$287K Buy
6,176
+1,347
+28% +$64.1K 0.26% 153
2024
Q2 		$238K Sell
4,829
-5,109
-51% -$208K 0.31% 135
2024
Q1 		$341K Sell
9,938
-3,433
-26% -$124K 0.25% 135
2023
Q4 		$493K Buy
+13,371
New +$309K 0.36% 102

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chesapeake Capital Corp's TWST Position: Q4 2024 in Review

Chesapeake Capital Corp reduced its Twist Bioscience (TWST) stake by 0.45% in Q4 2024, selling an estimated $1.26K and leaving 6,148 shares worth $286K. The position accounts for 0.29% of the portfolio, ranked #141.

Chesapeake Capital Corp first reported a position in TWST in Q4 2023 and has held it in 5 quarters since. The position peaked at $493K in Q4 2023. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Chesapeake Capital Corp held 6,148 shares of Twist Bioscience worth $286K as of Q4 2024.
  • Chesapeake Capital Corp sold 28 Twist Bioscience shares in Q4 2024, an estimated $1.26K.
  • Twist Bioscience made up 0.29% of Chesapeake Capital Corp's portfolio in Q4 2024, its #141 holding.
  • Chesapeake Capital Corp first reported a position in Twist Bioscience in Q4 2023 and has held it in 5 quarters since.
  • Chesapeake Capital Corp's Twist Bioscience position peaked at $493K in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Chesapeake Capital Corp's 13F filing for Q4 2024, filed 11 Feb 2025.